Plain-English translation of NCT06855485 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new stent device called HANAROSTEN® HOT Plumber™ with Z-EUSIT™ that drains fluid collections (pseudocysts) that develop in or near the pancreas. The device is placed using an endoscope—a thin, flexible tube with a camera—guided by ultrasound, making it a much less invasive option than surgery. Researchers want to see if this treatment safely reduces the size of these fluid collections and improves your symptoms.
Pancreatic pseudocysts can cause pain, nausea, weight loss, and other serious complications. While endoscopic drainage is already standard treatment, this medication uses a newer delivery system that may be easier and safer to place, require fewer additional procedures, and reduce the risk of complications.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo a minimally invasive endoscopic procedure where doctors use ultrasound guidance to place the new stent device to drain the fluid collection from your pancreas. You will receive sedation and antibiotics to keep you comfortable and safe. After the procedure, you'll have follow-up visits to monitor how well the stent is working and check for any side effects, continuing until one month after the stent is removed.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
South Korea